Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery.
about
What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.Intraperitoneal immunotherapy: historical perspectives and modern therapy.Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies.Evaluation of the peritoneal carcinomatosis index with CT and MRI.Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay.
P2860
Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Resectability of Peritoneal Ca ...... ted for Cytoreductive Surgery.
@en
type
label
Resectability of Peritoneal Ca ...... ted for Cytoreductive Surgery.
@en
prefLabel
Resectability of Peritoneal Ca ...... ted for Cytoreductive Surgery.
@en
P2093
P2860
P1476
Resectability of Peritoneal Ca ...... ted for Cytoreductive Surgery.
@en
P2093
Eddy Cotte
François-Noël Gilly
Guillaume Passot
Lorraine Bernard
Naoual Bakrin
Pascal Rousset
Pierre-Jean Valette
Stanislas Ledochowski
P2860
P2888
P304
P356
10.1245/S10434-015-5005-2
P577
2015-12-01T00:00:00Z
P5875
P6179
1018941361